Authors


Michelle Bolas

Latest:

Innovative Melanoma Treatment Among NCInnovation's $5.2 Million Research Funding Recipients

Michelle Bolas and Rukiyah T. Van Dross-Anderson, PhD, discuss the significance of NCInnovations’ funding and the clinical impact of Van Dross-Anderson's research in patients with advanced melanoma.


Omar Noor, MD, FAAD

Latest:

Optimizing Patient Communication and Treatment Efficacy Beyond Topical Steroids

Omar Noor, MD, FAAD, hosted a live Case-Based Roundtable discussion with local dermatology clinicians to discuss 2 patients with plaque psoriasis and what would be the ideal topical treatment for each.


Miranda Uzoma Ewelukwa, MD, FAAD

Latest:

Improving Representation of Skin of Color in Dermatology

Miranda Uzoma Ewelukwa, MD, FAAD, reviews how skin of color representation has evolved in dermatology, however, more advocacy is still needed.


Viktoriya Avlasevich, PharmD

Latest:

The Adalimumab Biosimiliar Pipeline: What's Ahead

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.


Keith Algozzine

Latest:

How a digital front door can improve patients’ access to care

Online-first engagement ensures patients obtain the right care for their specific needs.


Nanette Silverberg, MD

Latest:

Nanette Silverberg, MD: Taking an Aggressive Treatment Approach to Progressive Vitiligo

Silverberg discusses her SPD 2024 lecture, "Approach to Progressive Vitiligo," the future vitiligo landscape, and more.


Anthony Nuara, MD, PhD

Latest:

Post-Relapse Treatment of a 50-Year-Old Male Patient with Vitiligo

Continuing the discussion of a 50-year-old male patient with vitiligo, Anthony Nuara, MD, PhD, addresses the intricacies of treating patients who have relapsed or experienced a loss of efficacy following their initial treatment and highlights how to select 2nd line treatments with greater efficacy.


Brent Moody, MD, FACP, FAAD

Latest:

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.



Sherry G. Cohen, FNP-C, APRN-PMH

Latest:

Sunscreen Protection for Children

Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course for your patients and their families on sun protection, which can go a long way in preventing skin damage and disorders due to the sun.


Chesahna Kindred, MD, MBA, FAAD

Latest:

Addressing Causes of Female Hair Loss and Exploring Preventative Measures

This expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.


Dustin Portela, DO

Latest:

Pointers With Portela: Minimalist Skin Care Routines

In this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.



Aaron S. Farberg, M.D., dermatologist, Baylor Scott & White Health System and Bare Dermatology in Dallas, Texas

Latest:

Impact of Data on Generalized Pustular Psoriasis

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.


Ethan Sims, MD

Latest:

Addressing the Health Impacts of a Changing Climate

Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.


Andy Curry, PhD

Latest:

Unmasking Botulinum Toxin Myths

Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.


Gianna Melendez, MS, Spherix Global Insights

Latest:

Delving Into NP/PA Perspectives on Emerging Atopic Dermatitis Treatment Options

Explore how surveyed providers perceive current and emerging therapies in the atopic dermatitis.


Jay A. Lieberman, MD, FACAAI

Latest:

Jay A. Lieberman, MD, FACAAI: Clinical Pearls and Hands-On Educational Opportunities at ACAAI Annual Meeting

Program Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.


Meenal Kheterpal, MD

Latest:

Key Takeaways on Advanced BCC Management

Panelists discuss how advanced basal cell carcinoma (BCC) management requires a nuanced approach, emphasizing the importance of early detection, multidisciplinary collaboration, personalized treatment strategies, and ongoing patient monitoring to optimize outcomes and quality of life.



Hailey Brickman, PA-C

Latest:

QUIZ: Sauna-Related Rash - Test Your Medical Insight

“Edward” is a 35-year-old Hispanic male presenting with a new rash on the buttocks which has been present for approximately 1 month.


Linda Stein Gold, MD

Latest:

Enhancing Atopic Dermatitis Treatment: Insights From Cutting-Edge Studies and Clinical Perspectives Part 3

A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.


Jennifer Conner, MPAS, PA-C

Latest:

Take-Home Pearls on the Management of Plaque Psoriasis

Alexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.



Tom Ferry, MBA

Latest:

How Physicians Can Provide Better Care for Patients with Chronic Conditions

Technology and care navigators are key to managing this growing population


Lily Guo

Latest:

Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic Dermatitis

Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.


Bob Peelman

Latest:

Do You Have the Right Financial Adviser?

Experts detail 5 tips to ask a financial advisor so they can best serve your interests.



James Q. Del Rosso, DO

Latest:

The Latest in Dermatology With James Del Rosso, DO: Part 2

Del Rosso reviews available and upcoming monoclonal antibodies, including nemolizumab, lebrikizumab, bimekizumab, and more.


Theresa A. Bingemann, MD, FACAA

Latest:

Exploring the Diagnostics of Urticaria at ACAAI

Session at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.

© 2024 MJH Life Sciences

All rights reserved.